Artiva Biotherapeutics, Inc. — Income Charts
4 quarters of history · ending 2024-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue
$0
R&D
$13M
D&A
$614K
Operating Income
$-18M
EBITDA
$614K
Net Income
$-17M
Operating Margin
-5773.7%
Net Margin
-5562.9%
ETR (Continuing Operations)
0.0%
ETR Federal Statutory
21.0%
ETR State + Local (pp)
0.4%
Operating Lease Cost
$1M
Revenue YoY Variation
-100.0%
Income YoY Variation
-269.6%
Revenue QoQ Variation
-100.0%
Income QoQ Variation
-13.2%